356 related articles for article (PubMed ID: 32575633)
1. Epidemiological and Clinical Evidence for the Role of Toxins in
Bennett MR; Thomsen IP
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575633
[No Abstract] [Full Text] [Related]
2. Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis.
Dunyach-Remy C; Ngba Essebe C; Sotto A; Lavigne JP
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399775
[TBL] [Abstract][Full Text] [Related]
3. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection.
Shettigar K; Murali TS
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2235-2246. PubMed ID: 32683595
[TBL] [Abstract][Full Text] [Related]
4. Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.
DuMont AL; Torres VJ
Trends Microbiol; 2014 Jan; 22(1):21-7. PubMed ID: 24231517
[TBL] [Abstract][Full Text] [Related]
5. HOST-PATHOGEN INTERACTION IN INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS. STAPHYLOCOCCUS AUREUS VIRULENCE FACTORS.
Drăgulescu EC; Codiţă I
Roum Arch Microbiol Immunol; 2015; 74(1-2):46-64. PubMed ID: 26727854
[TBL] [Abstract][Full Text] [Related]
6. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.
Miller LS; Fowler VG; Shukla SK; Rose WE; Proctor RA
FEMS Microbiol Rev; 2020 Jan; 44(1):123-153. PubMed ID: 31841134
[TBL] [Abstract][Full Text] [Related]
7. Concise survey of Staphylococcus aureus virulence factors that promote adhesion and damage to peri-implant tissues.
Arciola CR; Visai L; Testoni F; Arciola S; Campoccia D; Speziale P; Montanaro L
Int J Artif Organs; 2011 Sep; 34(9):771-80. PubMed ID: 22094556
[TBL] [Abstract][Full Text] [Related]
8. Infection of Primary Human Alveolar Macrophages Alters Staphylococcus aureus Toxin Production and Activity.
Brann KR; Fullerton MS; Onyilagha FI; Prince AA; Kurten RC; Rom JS; Blevins JS; Smeltzer MS; Voth DE
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010814
[TBL] [Abstract][Full Text] [Related]
9. From Commensal to Consumer:
Nguyen AT; Tallent SM
J AOAC Int; 2018 Jul; 101(4):1127-1134. PubMed ID: 29216934
[TBL] [Abstract][Full Text] [Related]
10. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
11. Clonal differences in Staphylococcus aureus bacteraemia-associated mortality.
Recker M; Laabei M; Toleman MS; Reuter S; Saunderson RB; Blane B; Török ME; Ouadi K; Stevens E; Yokoyama M; Steventon J; Thompson L; Milne G; Bayliss S; Bacon L; Peacock SJ; Massey RC
Nat Microbiol; 2017 Oct; 2(10):1381-1388. PubMed ID: 28785103
[TBL] [Abstract][Full Text] [Related]
12.
Ahmad-Mansour N; Loubet P; Pouget C; Dunyach-Remy C; Sotto A; Lavigne JP; Molle V
Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678970
[No Abstract] [Full Text] [Related]
13. Novel Regulation of Alpha-Toxin and the Phenol-Soluble Modulins by Peptidyl-Prolyl
Keogh RA; Zapf RL; Trzeciak E; Null GG; Wiemels RE; Carroll RK
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31208155
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus: a pathogen with still unresolved issues.
Rasigade JP; Vandenesch F
Infect Genet Evol; 2014 Jan; 21():510-4. PubMed ID: 23994773
[TBL] [Abstract][Full Text] [Related]
15. Phenol-soluble modulins and staphylococcal infection.
Peschel A; Otto M
Nat Rev Microbiol; 2013 Oct; 11(10):667-73. PubMed ID: 24018382
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease.
Jenkins A; Diep BA; Mai TT; Vo NH; Warrener P; Suzich J; Stover CK; Sellman BR
mBio; 2015 Feb; 6(1):e02272-14. PubMed ID: 25691592
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the presence of Panton-Valentine leukocidin and clonal relationship of community- and hospital-acquired clinical isolates of Staphylococcus aureus].
Duman Y; Tekeroğlu MS; Otlu B
Mikrobiyol Bul; 2013 Jul; 47(3):389-400. PubMed ID: 23971918
[TBL] [Abstract][Full Text] [Related]
18. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
[TBL] [Abstract][Full Text] [Related]
19. Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy.
Kong C; Neoh HM; Nathan S
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999200
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
Seilie ES; Bubeck Wardenburg J
Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
